Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 22, 2021 07:00 ET | Source: INNATE PHARMA

Innate Pharma présente des données préliminaires de l'essai TELLOMAK montrant une réponse clinique avec lacutamab dans le mycosis fungoides

Marseille, 22 juin 2021 (GLOBE NEWSWIRE) -- Les premières données cliniques de TELLOMAK établissent la sécurité de lacutamab, des réponses cliniques ainsi qu’une amélioration au niveau de la peau...
June 22, 2021 07:00 ET | Source: INNATE PHARMA

Innate Pharma presents preliminary data from TELLOMAK trial showing clinical response for lacutamab in mycosis fungoides

Marseille, June 22, 2021 (GLOBE NEWSWIRE) -- First data set from TELLOMAK establishes safety, clinical responses and skin improvement in patients with mycosis fungoides that express KIR3DL2 Data...
February 03, 2021 01:00 ET | Source: INNATE PHARMA

Innate Pharma to Host Key Opinion Leader Discussion on the Potential Role of Lacutamab Across T-Cell Lymphomas

MARSEILLE, France, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that it will host a virtual...
November 13, 2020 01:00 ET | Source: INNATE PHARMA

INNATE PHARMA RECEIVES PRIME DESIGNATION FROM THE EUROPEAN MEDICINES AGENCY FOR LACUTAMAB IN SÉZARY SYNDROME

Marseille, France, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the European Medicines...
November 13, 2020 01:00 ET | Source: INNATE PHARMA

INNATE PHARMA REÇOIT LE STATUT « PRIME » DE L’AGENCE EUROPÉENNE DU MÉDICAMENT POUR LACUTAMAB DANS LE SYNDROME DE SÉZARY

Marseille, France, 13 nov. 2020 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris : IPH – ISIN : FR0010331421 ; Nasdaq : IPHA) (« Innate » ou la « Société ») a annoncé que l’Agence Européenne...
June 24, 2020 01:00 ET | Source: INNATE PHARMA

U.S. Food and Drug Administration Lifts Partial Clinical Hold on Lacutamab TELLOMAK Trial in Advanced T-Cell Lymphomas

Innate Pharma to re-activate TELLOMAK trial in the US New GMP-certified batch has been successfully manufactured Conference call to be held today on the lacutamab clinical trial program ...